Literature DB >> 23496037

The importance of plasma protein binding in drug discovery.

George L Trainor1.   

Abstract

Plasma protein binding of drugs is a well-recognised phenomena, but it is only recently that the implications for drug action in vivo have been fully appreciated. Plasma proteins, by virtue of their high concentration, control the free drug concentration in plasma and in compartments in equilibrium with plasma, thereby, effectively attenuating drug potency in vivo. The historical background and thermodynamic basis for the 'Free Drug Principle' is presented, along with special considerations for intracellular targets, deep compartments and α1-acid glycoprotein binding. Real and apparent exceptions to the principle are discussed along with a survey of citations from the recent medicinal chemistry literature.

Year:  2007        PMID: 23496037     DOI: 10.1517/17460441.2.1.51

Source DB:  PubMed          Journal:  Expert Opin Drug Discov        ISSN: 1746-0441            Impact factor:   6.098


  45 in total

1.  The male genital tract is not a pharmacological sanctuary from efavirenz.

Authors:  L B Avery; R P Bakshi; Y J Cao; C W Hendrix
Journal:  Clin Pharmacol Ther       Date:  2011-06-01       Impact factor: 6.875

2.  Calculation of normalized drug concentrations in the presence of altered plasma protein binding.

Authors:  Florin Marcel Musteata
Journal:  Clin Pharmacokinet       Date:  2012-01-01       Impact factor: 6.447

Review 3.  The effect of plasma protein binding on in vivo efficacy: misconceptions in drug discovery.

Authors:  Dennis A Smith; Li Di; Edward H Kerns
Journal:  Nat Rev Drug Discov       Date:  2010-12       Impact factor: 84.694

4.  Simulating the influence of plasma protein on measured receptor affinity in biochemical assays reveals the utility of Schild analysis for estimating compound affinity for plasma proteins.

Authors:  D Blakeley; D A Sykes; P Ensor; E Bertran; P J Aston; S J Charlton
Journal:  Br J Pharmacol       Date:  2015-10-22       Impact factor: 8.739

5.  Systems Approach to targeted and long-acting HIV/AIDS therapy.

Authors:  Rodney J Y Ho; Jesse Yu; Bowen Li; John C Kraft; Jennifer P Freeling; Josefin Koehn; Jingwei Shao
Journal:  Drug Deliv Transl Res       Date:  2015-12       Impact factor: 4.617

6.  Brain Distributional Kinetics of a Novel MDM2 Inhibitor SAR405838: Implications for Use in Brain Tumor Therapy.

Authors:  Minjee Kim; Janice K Laramy; Gautham Gampa; Karen E Parrish; Richard Brundage; Jann N Sarkaria; William F Elmquist
Journal:  Drug Metab Dispos       Date:  2019-10-16       Impact factor: 3.922

7.  The Presence of a Transporter-Induced Protein Binding Shift: A New Explanation for Protein-Facilitated Uptake and Improvement for In Vitro-In Vivo Extrapolation.

Authors:  Christine M Bowman; Hideaki Okochi; Leslie Z Benet
Journal:  Drug Metab Dispos       Date:  2019-01-23       Impact factor: 3.922

8.  Albumin-Based Transport of Nonsteroidal Anti-Inflammatory Drugs in Mammalian Blood Plasma.

Authors:  Mateusz P Czub; Katarzyna B Handing; Barat S Venkataramany; David R Cooper; Ivan G Shabalin; Wladek Minor
Journal:  J Med Chem       Date:  2020-06-17       Impact factor: 7.446

9.  Studies of verapamil binding to human serum albumin by high-performance affinity chromatography.

Authors:  Rangan Mallik; Michelle J Yoo; Sike Chen; David S Hage
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2008-10-21       Impact factor: 3.205

10.  Ontogeny of plasma proteins, albumin and binding of diazepam, cyclosporine, and deltamethrin.

Authors:  Pankaj K Sethi; Catherine A White; Brian S Cummings; Ronald N Hines; Srinivasa Muralidhara; James V Bruckner
Journal:  Pediatr Res       Date:  2015-11-16       Impact factor: 3.756

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.